The issue of comparators in economic evaluations of biologic response modifiers in rheumatoid arthritis

Nov 11, 2017 by in RHEUMATOLOGY Comments Off on The issue of comparators in economic evaluations of biologic response modifiers in rheumatoid arthritis

Introduction Over the last decade, a number of biologic response modifiers (BRMs) have emerged and transformed rheumatoid arthritis (RA) management. Due to their relatively high costs, economic evaluations have attempted…

read more

Impact of socioeconomic gradients within and between countries on health of patients with rheumatoid arthritis (RA): Lessons from QUEST RA

Nov 11, 2017 by in RHEUMATOLOGY Comments Off on Impact of socioeconomic gradients within and between countries on health of patients with rheumatoid arthritis (RA): Lessons from QUEST RA

In this chapter, we discuss challenges in collecting data on outcomes of patients who receive usual rheumatology care. We present results of the multinational Quantitative Monitoring of Patients with Rheumatoid…

read more

Compromised access to prescriptions and medical care because of cost among US adults with arthritis

Nov 11, 2017 by in RHEUMATOLOGY Comments Off on Compromised access to prescriptions and medical care because of cost among US adults with arthritis

Introduction Study objectives were to: 1) determine the magnitude of three outcomes (prescription unaffordable, care delayed and needed care not obtained) related to cost-attributable compromised medical care access among US…

read more

Impact of co-morbidities on measuring indirect utility by the Medical Outcomes Study Short Form 6D in lower-limb osteoarthritis

Nov 11, 2017 by in RHEUMATOLOGY Comments Off on Impact of co-morbidities on measuring indirect utility by the Medical Outcomes Study Short Form 6D in lower-limb osteoarthritis

Introduction Co-morbidities can influence generic measurement of health indirect utility. We investigated their impact to assess indirect utility with the Medical Outcomes Study Short Form 6D (SF-6D) in patients with…

read more

Cost implications of self-management education intervention programmes in arthritis

Nov 11, 2017 by in RHEUMATOLOGY Comments Off on Cost implications of self-management education intervention programmes in arthritis

The purpose of this review is to examine cost implications, including cost-effectiveness analyses, cost-savings calculated from health-care utilisation and intervention delivery costs of arthritis-related self-management education (SME) interventions. Methods Literature…

read more
Get Clinical Tree app for offline access